We have discovered that the strain CB1370 has a mean life span twice that of N2 when raised at 20 . The mean life span of CB1370 is 45 days whereas the mean life span of N2 is 21 days. The increase in life span of this strain is striking. After 31 days, when all the N2 worms have died, 84% of the CB1370 worms are still alive and moving well on their plates. CB1370 contains the mutation
daf-2 (
e1370).
daf-2 (
e1370Jis a temperature-sensitive dauer-constitutive mutation. Worms hatched and raised at 25 enter dauer and remain as dauer larvae until shifted to the non-permissive temperature of 20 . Dauer larvae are morphologically different from non-dauer animals and have an increased life span. At 20 CB1370 exhibits increased longevity but not other dauer phenotypes. It eats and produces progeny, and it looks much like a normal non-dauer animal. We have also observed a similar increase in life span when CB1370 worms are hatched at 20 and shifted to 25 as L4 sor early adults. This increase in life span is not as dramatic, however, because a large number of CB1370 worms become bags at 25 . It has generally been assumed the dauer lives longer simply because it is relatively metabolically inert. However, this result suggests that perhaps the longevity of the dauer is not simply due to its being in a state of suspended animation. Instead, there may be a longevity program latent in the non-dauer worm that can, if activated, prolong its life substantially. The longevity program is normally activated along with other aspects of dauer morphogenesis, but the increased lifespan of
daf-2 (1370)mutants suggests that it can function independently. Although the mutation in
daf-2 is the most likely reason for increased longevity in CB1370 ,there is the possibility that CB1370 contains a second mutation, in an "aging" gene and that
daf-2 (
e1370)has no longevity phenotype. In order to differentiate between these two possibilities we are currently testing other
daf-2 alleles for increased life span. Preliminary findings suggest that
daf-2 (
sa193),kindly sent to us by Jim Thomas, also lives longer than the wild-type. We conclude that
daf-12 wild-type activity is dispensible for the heterochronic expression of the L1 -specificantigen caused by the dauer-constitutive mutations we tested. In contrast, both
daf-3 and
daf-5 wildtype activity are required for the Srf heterochronic phenotype. Our interpretation of these results is that the daf-c gene products signal to both dauer formation and surface antigen switching, but through downstream steps that eventually split into process-specific branches. Incorporating our results into the pathway hypothesized for dauer formation based on epistasis analysis, one such branch point would be downstream of the daf-c genes (with the exception of
daf-2 )and daf-d genes
daf-3 and
daf-5 .but upstream of
daf-12 (see Figure). We would also like to place
srf-6 in this model by epistasis analysis. If
daf-3 and
daf-5 are epistatic to
srf-6 for the Srf heterochronic phenotype, it would suggest that the
srf-6 product acts upstream of these steps. On the other hand, if
srf-6 mutants still express the Srf heterochronic phenotype in the presence of these daf-d mutations, it would suggest that
srf-6 acts in a surface antigen-specific way, perhaps downstream of the branchpoint proposed above. We plan to construct the appropriate double mutants to test these hypotheses. To summarize, every daf mutation we have tested so far except for
daf-2 and
daf-12 mutations also affects the surface antigen switching detected with monoclonal antibody M37 .Because it involves the continued expression of a marker normally expressed on the first larval stage, the Srf heterochronic phenotype is reminiscent of the propensity of mammalian cancer cells to express so-called "carcinoembryonic" or "oncodevelopmental" surface antigens characteristic of embryonic or fetal cells. It remains to be seen whether the effects of the daf genes on surface antigen switching observed in this formal analysis signify a molecular involvement of the gene products in signalling to two distinct processes. We thank Don Riddle and Patrice Albert for encouragement and for gifts of double mutant strains, and Victor Ambros, Gary Ruvkun, and Jim Thomas for discussion.